Tanycyte-Derived Lactate Activates Astrocytic HCAR1 to Modulate Glutamatergic Signaling and POMC Neuron Excitability

For decades, the intricate mechanisms governing appetite have been predominantly attributed to the sophisticated communication networks of neurons, the brain’s principal electrical signaling cells. However, a groundbreaking study published on April 6, 2026, in the prestigious journal Proceedings of the National Academy of Sciences is significantly reshaping this long-held scientific consensus. Researchers from the University of Concepción in Chile, in collaboration with esteemed colleagues at the University of Maryland, have unveiled compelling evidence that astrocytes, traditionally relegated to a supportive role for neurons, are far more active participants in the complex regulation of hunger and satiety than previously understood. This discovery, rooted in the identification of a novel signaling pathway within the hypothalamus, the brain’s central command for appetite, holds profound implications for the future development of therapeutic interventions for a spectrum of metabolic and eating disorders, including obesity.

The prevailing paradigm in neuroscience has long emphasized the neuron as the primary architect of brain function. "People tend to immediately think of neurons when they think about how the brain works," explained Ricardo Araneda, a distinguished professor in the Department of Biology at the University of Maryland and a corresponding author on the study. "But we’re finding that astrocytes, what we used to think of as just secondary support cells, are also participating in how our brains regulate how much we eat. This research changes how we think about these communication circuits." This paradigm shift suggests that a more nuanced understanding of glial cells, particularly astrocytes, is crucial for deciphering the full complexity of neural information processing.

The Glucose Cascade: From Tanycytes to the Hypothalamus

The newly elucidated pathway begins with a specialized class of cells known as tanycytes. These cells are strategically located, lining a fluid-filled cavity deep within the brain, a critical vantage point for monitoring the body’s metabolic status. Their primary function in this context is to act as sophisticated sensors for glucose, the body’s primary fuel source, as it circulates through the cerebrospinal fluid.

Following a meal, a natural and expected surge in blood glucose levels occurs. Tanycytes, attuned to these physiological changes, respond by actively processing this available glucose. In doing so, they release lactate, a metabolic byproduct of glucose metabolism, into the surrounding brain tissue. This released lactate then initiates the subsequent stage of intercellular communication by interacting with neighboring astrocytes.

Previously, scientific inquiry had posited that the lactate produced by tanycytes directly engaged with neurons involved in appetite control. However, the current research has identified an essential intermediary in this vital conversation. "Researchers used to think that lactate produced from tanycytes ‘spoke’ directly to neurons involved in appetite control," Araneda elaborated. "But we found that there was an unexpected middleman in that conversation, astrocytes." This revelation underscores the importance of glial cells in relaying and modulating neural signals, moving beyond their traditional "housekeeping" roles.

Astrocytes: Beyond Support to Active Signaling

Astrocytes, the most abundant cell type in the brain, have historically been characterized by their supportive functions, providing structural integrity, regulating the extracellular environment, and supplying nutrients to neurons. This study, however, provides irrefutable evidence of their direct involvement in signaling pathways that influence fundamental behaviors like eating.

The research team’s meticulous investigations revealed that astrocytes possess a specific receptor, known as HCAR1 (Hydroxycarboxylic acid receptor 1), which is uniquely capable of detecting lactate. Upon binding of lactate to the HCAR1 receptor, astrocytes are activated. This activation triggers a cascade of intracellular events that culminates in the release of glutamate, a principal excitatory neurotransmitter in the central nervous system. This glutamate signal is then transmitted to specific neurons within the hypothalamus that are known to suppress appetite, thereby contributing to the physiological sensation of fullness or satiety.

"What surprised us was the complexity of it," Araneda remarked, reflecting on the intricate nature of the discovered mechanism. "To put it simply, we found that tanycytes ‘talk’ to astrocytes, and then astrocytes ‘talk’ to neurons." This elegant, multi-step communication chain highlights a sophisticated interplay between different cell types, orchestrated to maintain energy homeostasis.

A Neural Symphony: The Propagation of Appetite Signals

Further experimental evidence has illuminated the dynamic nature of this signaling process. In one particularly revealing experiment, scientists meticulously introduced glucose to a single tanycyte while simultaneously monitoring the activity of adjacent astrocytes. The results demonstrated that even this localized metabolic change was sufficient to trigger a wave of activity across multiple surrounding astrocytes. This observation vividly illustrates how signals can propagate and amplify through the brain’s intricate cellular network, impacting a broader region.

Araneda also noted the potential for a dual regulatory effect. The hypothalamus is known to harbor two distinct and opposing neuronal populations: those that stimulate hunger and those that inhibit it. "We also noticed a dual effect of sorts," Araneda observed. "The hypothalamus contains two opposing populations of neurons: those that promote hunger and those that suppress it. We found that it might be possible that lactate can work on both simultaneously — activating the fullness neurons through astrocytes, while potentially quieting the hunger neurons through a more direct route." This dual action suggests a highly refined system for fine-tuning appetite signals.

Implications for Metabolic Health: A New Frontier in Treatment

While the research was primarily conducted using animal models, the fundamental biological structures involved—tanycytes and astrocytes—are conserved across all mammalian species, including humans. This high degree of conservation strongly suggests that the same intricate signaling mechanism is likely operational in the human brain, offering a tangible basis for potential therapeutic applications.

The immediate next phase of research for the team involves directly testing the hypothesis that modulating the HCAR1 receptor in astrocytes can indeed influence eating behavior. This critical step is paramount before any translation to human therapies can be considered. Currently, no pharmaceutical interventions are specifically designed to target this newly identified pathway. However, Professor Araneda expresses considerable optimism about its therapeutic potential.

"We now have a different mechanism where we might be able to target astrocytes or specifically this HCAR1 receptor," he stated. "It would be a novel target that may complement existing therapies like Ozempic, for example, and improve the lives of many who suffer from obesity and other appetite-related conditions." The prospect of developing novel treatments that can complement or enhance existing interventions, such as GLP-1 receptor agonists which have revolutionized obesity management, represents a significant advancement in the fight against these pervasive health challenges.

A Decade of Dedication: The Genesis of a Discovery

This landmark discovery is the culmination of nearly a decade of dedicated, collaborative scientific effort. The research team is comprised of scientists from Professor Araneda’s laboratory at the University of Maryland and the laboratory of María de los Ángeles García-Robles at the University of Concepción, who served as the principal investigator for the project. The lead author of the study, Sergio López, a doctoral student co-mentored by both researchers, conducted the pivotal experiments during an extensive eight-month research visit to the University of Maryland. This extended period of cross-institutional collaboration highlights the sustained commitment required for fundamental scientific breakthroughs.

The comprehensive research paper detailing these findings, titled "Tanycyte-derived lactate activates astrocytic HCAR1 to modulate glutamatergic signaling and POMC neuron excitability," provides an in-depth analysis of the experimental methodologies and results. Its publication in the Proceedings of the National Academy of Sciences signifies its rigorous peer review and substantial contribution to the scientific literature.

The research was generously supported by grants from Chile’s National Fund for Scientific and Technological Development, the Millennium Institute of Neuroscience in Valparaíso, and the U.S. National Institutes of Health (Award No. R01AG088147A). While these funding bodies have played a crucial role in enabling this scientific endeavor, the views expressed in the article are solely those of the researchers and do not necessarily reflect the official policies or positions of these organizations. This collaborative spirit, spanning continents and institutions, exemplifies the global nature of scientific advancement and its potential to profoundly impact human health. The ongoing investigation into the precise roles of astrocytes in appetite regulation promises to unlock new avenues for understanding and treating conditions that affect millions worldwide.